Journal Article Summary
The article investigates the development of controlled release matrix tablets for losartan potassium, a medication commonly used to manage high blood pressure. The significance of this research lies in the potential benefits of controlled release systems, which can provide a steady release of medication over an extended period, thereby reducing the frequency of dosing and improving patient adherence to treatment. By exploring new combinations of polymers, the study aims to enhance the effectiveness and convenience of losartan potassium delivery.
In this study, researchers prepared losartan potassium tablets using a combination of Ethocel grade 100 and Carbopol 934P NF, employing various ratios of these polymers to assess their impact on drug release. The tablets were created through direct compression, and their dissolution was tested in a phosphate buffer solution. Results indicated that the combination of Ethocel and Carbopol effectively extended the drug release for up to 24 hours, with certain formulations showing enhanced release rates when co-excipients like HPMC, CMC, and starch were included. The release mechanism was identified as anomalous non-Fickian diffusion, suggesting a complex interaction between the drug and the polymers.
Despite the promising findings, the study does have limitations, including the need for further clinical validation to ensure safety and efficacy in real-world settings. Patients should consult with healthcare professionals before making any changes to their medication regimen, especially regarding the use of controlled release formulations. It is essential to discuss any concerns about medication adherence and the potential benefits of such formulations with a doctor or pharmacist to ensure optimal treatment outcomes.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Khan Kamran Ahmad, Khan Gul Majid, Muzammal Muhammad, Al Mohaini Mohammed, Alsalman Abdulkhaliq J., Al Hawaj Maitham A., Ahmad Ashfaq, Niazi Zahid Rasul, et al.. Preparation of Losartan Potassium Controlled Release Matrices and In-Vitro Investigation Using Rate Controlling Agents. Molecules 2022. DOI: 10.3390/molecules27030864. PMID: 35164127. PMCID: PMC8839457.
Featured Pill Pals Product
Losartan 25 mg Tablets --- 30 Count --- Generic For Cozaar --- Zydus Pharma
Losartan 25 mg Tablets — 30 Count — Generic For Cozaar — Zydus Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
